The role of nutrients in the prevention of cervical dysplasia and cancer

Nutrition

Volumn 16, Issue 7-8, 2000, Pages 570-573

  Giuliano, Anna R ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CONFERENCE PAPER; FEMALE; HUMAN; NUTRITION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ANTIOXIDANTS; FEMALE; HUMANS; NUTRITION PHYSIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REACTIVE OXYGEN SPECIES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 0034235945     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00338-5     Document Type: Conference Paper

References (36)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the world-wide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594.
2. Kurman R.J., Henson D.E., Herbst A.L., et al. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 272:1994;1866.
3. Morrow C.P., Cozen W. Perspective on cervical cancer why prevent? J Cell Biochem. 23:(suppl):1995;61.
4. Schiffman M.H. New epidemiology of human papillomavirus infection and cervical neoplasia. JNCI. 87:1995;1345.
5. Palefsky J.M., Holly E.A. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomark Prev. 4:1995;415.
6. Koutsky L.A., Holmes K.H., Critchlow C.W., et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 327:1992;1272.
7. Franco EL, Villa LL, Rahal P, Ferenczy A, Rohan TE. Risk of cervical intraepithelial neoplasia following transient and persistent HPV infection. Presented at the 15th International Papillomavirus Conference, Gold Coast, Australia, December 1996.
8. Ho G.Y., Burk R.D., Kein S., et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 87:1995;1365.
9. Cuzick J., Terry G., Ho L., Hollingsworth T., Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer. 69:1994;167.
10. Villa LL, Franco EL, Caballero O, et al. Viral load, persistent cervical HPV infection, and cumulative risk of cervical intraepithelial neoplasia in a high risk area. Presented at the 15th International Papillomavirus Conference, Gold Coast, Australia, December 1996.
11. Giuliano A.R., Papenfuss M., Nour M., et al. Antioxidant nutrients associations with persistent human papillomavirus infection . Cancer Epidemiol Biomark Prev. 8:1997;917.
12. Potischman N., Brinton L.A. Nutrition and cervical dysplasia. Cancer Causes Control. 7:1996;113.
13. Basu J., Palan P.R., Vermund S.H., et al. Plasma ascorbic acid and β-carotene levels in women evaluated for HPV infection, smoking, and cervical dysplasia. Cancer Det Prev. 15:1991;167.
14. Potischman N., Herrero R., Brinton L.A., et al. A case-control study of nutrient status and invasive cervical cancer. Am J Epidemiol. 134:1991;1347.
15. Potischman N., Hoover R., Brinton L.A., et al. The relations between cervical cancer and serological markers of nutritional status. Nutr Cancer. 21:1994;193.
16. Van Eenwyk J., Davis F., Bowen P. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer. 48:1991;34.
17. Palan P., Mikhail M., Goldberg G., et al. Plasma levels if β-carotene, lycopene, canthaxanthin, retinol, α-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res. 2:1996;181.
18. Batieha A.M., Armenian H.K., Morris J.S., Spate V.E., Comstock G.W. Serum micronutrients and the subsequent risk of cervical cancer in a population based nested case-control study. Cancer Epidemiol Biomark Prev. 2:1993;335.
19. Clinton S.K., Emenhiser C., Schwartz S.J., et al. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomark Prev. 5:1996;823.
20. Mangels A.R., Holden J.M., Beecher G.R., Froman M., Lanza E. Carotenoid content of fruits and vegetables an evaluation of analytic data . J Am Diet Assoc. 93:1993;284.
21. Brock K., Berry G., Mock P., et al. Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst. 80:1988;580.
22. Palan P., Mikhail M., Basu J., Romney S. Plasma levels of antioxidant β-carotene and α-tocopherol in uterine cervix dysplasia and cancer. Nutr Cancer. 15:1991;13.
23. Knekt P. Serum vitamin E level and risk of female cancers. Int J Epidemiol. 17:1988;281.
24. Cuzick J., de Stvola B., Russel M., Thomas B. Vitamin A, vitamin E, and the risk of cervical intraepithelial neoplasia. Br J Cancer. 62:1990;651.
25. Kwasniewska A., Tukendorf A., Semczuk M. Content of α-tocopehrol in blood serum of human papillomavirus-infected women with cervical dysplasias. Nutr Cancer. 28:1997;248.
26. Giuliano A.R., Gapstur S. Can cervical dysplasia and cancer be prevented with nutrients? Nut Rev. 56:1998;9.
27. Palmer H.J., Paulson K.E. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev. 55:1997;353.
28. Beck M.A., Shi Q., Morris V.C., Levander O.A. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med. 1:1995;433.
29. Peterhans E. Oxidants and antioxidants in viral diseases disease mechanisms and metabolic regulation . J Nutr. 127:1997;962S.
30. Hennet T., Perhans E., Stocker R. Alterations in antioxidant defenses in lung and liver of mice infected with influenza-A virus. J Gen Virol. 73:1992;39.
31. Oda T., Akaike T., Hamamoto T., et al. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science. 244:1989;974.
32. Pace G.W., Leaf C.D. The role of oxidative stress in HIV disease. Free Rad Biol Med. 19:1995;523.
33. Packer L., Suzuki Y.J. Vitamin E and alpha-lipoate role in antioxidant recycling and activation of the NF-κB transcription factor . Mol Aspects Med. 14:1993;229.
34. Cripe T.P., Alderborn A., Anderson R.D., et al. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1 responsive modules. New Biol. 2:1990;450.
35. Offord E.A., Beard P. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J Virol. 64:1990;4792.
36. Rosl F., Das BC Lengert M., Geletneky K., zur Hausen H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol. 71:1997;362.